Cash & equivalents decreased 81.6%
Cash & equivalents changed -81.6% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -81.6% from the comparable as-filed period.
Net income changed +52.9% from the comparable as-filed period.
Operating margin changed -744940 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Revenue changed -51.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating cash flow changed +18.5% from the comparable as-filed period. The change ranks at the 14th percentile of 7 prior comparable changes.
Research & development changed +13.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Selling, general & administrative changed -15.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Stock-based compensation changed +16.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Operating income changed +5.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.